Triple negative breast cancer: Clinical characteristics in the different histological subtypes

被引:40
作者
Dreyer, Geertje [1 ]
Vandorpe, Thijs [2 ]
Smeets, Ann [2 ]
Forceville, Kathleen [1 ,2 ]
Brouwers, Barbara [1 ,2 ]
Neven, Patrick [2 ,3 ]
Janssens, Hilde [2 ,4 ]
Deraedt, Karen [2 ,5 ]
Moerman, Philippe [2 ,5 ]
Van Calster, Ben [6 ,7 ]
Christiaens, Marie-Rose [2 ]
Paridaens, Robert [1 ,2 ]
Wildiers, Hans [1 ,2 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Gen Med Oncol, Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, Multidisciplinary Breast Ctr, Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Gynecol Oncol, Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Radiotherapy, Louvain, Belgium
[5] Katholieke Univ Leuven Hosp, Dept Pathol, Louvain, Belgium
[6] Katholieke Univ Leuven Hosp, Dept Elect Engn ESAT SCD, Louvain, Belgium
[7] Katholieke Univ Leuven Hosp, Leuvens Kankerinst, Louvain, Belgium
关键词
Breast cancer; Triple negative; Histology; Outcome; Lymph node involvement; Apocrine breast cancer; EXPRESSION; CARCINOMA; FEATURES; RECEPTOR; RELAPSE;
D O I
10.1016/j.breast.2013.01.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the clinical behavior of triple negative breast cancer (TNC), including age distribution, occurrence of LN (lymph node) invasion and prognosis in different histological subtypes. Methods: For this cohort study we used data on 476 patients with newly diagnosed TNC at the University Hospitals Leuven (Belgium) between 1999 and 2009. Of these, 395 received upfront surgery, 68 neo-adjuvant chemotherapy and 21 had metastases at diagnosis. Results: Apocrine and invasive lobular TNC occur more often in older patients compared to IDC-NOS. Of the primarily operated patients with TNC, 35.1% has pathological LN involvement. There were no significant differences in nodal invasion between different histological subtypes, but most subtypes contained few patients. In contrast to previous reports, 6/14 of apocrine TNC had LN involvement. Disease free survival (DFS) was different in different histological subtypes, but group sizes were insufficient to be able to draw firm conclusions. Within the histologically 'homogeneous' IDC-NOS group with primary surgery and outcome data (n = 300), DFS with 3.5 year median follow-up decreased with increasing age, but chemotherapy and radiotherapy were much less frequently given with increasing age. In multivariable analysis, lower age, presence of LN involvement, lack of administration of chemotherapy and radiotherapy were significant predictors of relapse. Conclusion: TNC is not a uniform disease. Different histological subtypes have different age distribution and behavior. The prognosis of the most common histological subgroup, IDC-NOS, is better in older patients, but this is counterbalanced by significantly decreased use of chemotherapy and radiotherapy. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:761 / 766
页数:6
相关论文
共 50 条
  • [41] Is conservative surgery a good option for patients with "triple negative" breast cancer?
    Martinez-Ramos, David
    Escrig-Sos, Javier
    Torrella-Ramos, A.
    Alcalde-Sanchez, M.
    Salvador-Sanchis, J. L.
    BREAST, 2012, 21 (03) : 401 - 405
  • [42] Prognostic Role of Family History in Patients with Triple Negative Breast Cancer
    Altinok, Ayse
    Muslumanoglu, Mahmut
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2019, 34 (02): : 87 - 91
  • [43] Histological analysis of γδ T lymphocytes infiltrating human triple negative breast carcinomas
    Hidalgo, Jose Villacorta
    Bronsert, Peter
    Orlowska-Volk, Marzenna
    Diaz, Liliana B.
    Stickeler, Elmar
    Werner, Martin
    Schmitt-Graeff, Annette
    Kayser, Gian
    Malkovsky, Miroslav
    Fisch, Paul
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [44] Prognostic impact of histological subtyping in triple-negative breast cancer
    Grosse, Claudia
    Noack, Petar
    Grosse, Alexandra
    Preuss, Caroline Ines
    Schwarz, Heike Kathleen
    Gitter, Thomas
    Schrenk, Peter
    Frauchiger-Heuer, Heike
    Papassotiropoulos, Barbel
    Tausch, Christoph
    Maccio, Umberto
    Moch, Holger
    Langer, Rupert
    Varga, Zsuzsanna
    HUMAN PATHOLOGY, 2024, 152
  • [45] Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response
    Kim, Jihyun
    Yu, Doyeong
    Kwon, Youngmee
    Lee, Keun Seok
    Sim, Sung Hoon
    Kong, Sun-Young
    Lee, Eun Sook
    Park, In Hae
    Park, Charny
    MOLECULAR CANCER RESEARCH, 2020, 18 (02) : 253 - 263
  • [46] Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer
    Roudi, Raheleh
    Madjd, Zahra
    Korourian, Alireza
    Mehrazma, Mitra
    Molanae, Saadat
    Sabet, Mehrdad Nasrollahzadeh
    Shariftabrizi, Ahmad
    CANCER BIOMARKERS, 2014, 14 (06) : 457 - 467
  • [47] The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
    Fan, Yiqi
    He, Shuai
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1 - 17
  • [48] Expression changes of BIK in breast cancer tissues of different histological subtypes
    Ruiz-Esparza-Garrido, Ruth
    Torres-Lopez, Javier
    Pina-Sanchez, Patricia
    Viedma-Rodriguez, Rubi
    Rivera-Gonzalez, Alejandro
    Velazquez-Flores, Miguel A.
    CIRUGIA Y CIRUJANOS, 2020, 88 (02): : 163 - 169
  • [49] Triple-Negative Breast Cancer A Short Review
    Elias, Anthony D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 637 - 645
  • [50] Metabolic phenotypes in triple-negative breast cancer
    Kim, Sewha
    Kim, Do Hee
    Jung, Woo-Hee
    Koo, Ja Seung
    TUMOR BIOLOGY, 2013, 34 (03) : 1699 - 1712